Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

403 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk of Gleason Score 3+4=7 prostate cancer upgrading at radical prostatectomy is significantly reduced by targeted versus standard biopsy.
De Luca S, Fiori C, Bollito E, Garrou D, Aimar R, Cattaneo G, De Cillis S, Manfredi M, Tota D, Federica M, Passera R, Porpiglia F. De Luca S, et al. Among authors: cattaneo g. Minerva Urol Nefrol. 2020 Jun;72(3):360-368. doi: 10.23736/S0393-2249.19.03367-8. Epub 2019 Oct 10. Minerva Urol Nefrol. 2020. PMID: 31619029 Free article.
High prostate cancer gene 3 (PCA3) scores are associated with elevated Prostate Imaging Reporting and Data System (PI-RADS) grade and biopsy Gleason score, at magnetic resonance imaging/ultrasonography fusion software-based targeted prostate biopsy after a previous negative standard biopsy.
De Luca S, Passera R, Cattaneo G, Manfredi M, Mele F, Fiori C, Bollito E, Cirillo S, Porpiglia F. De Luca S, et al. Among authors: cattaneo g. BJU Int. 2016 Nov;118(5):723-730. doi: 10.1111/bju.13504. Epub 2016 May 24. BJU Int. 2016. PMID: 27112799
Multiparametric Magnetic Resonance/Ultrasound Fusion Prostate Biopsy: Number and Spatial Distribution of Cores for Better Index Tumor Detection and Characterization.
Porpiglia F, De Luca S, Passera R, De Pascale A, Amparore D, Cattaneo G, Checcucci E, De Cillis S, Garrou D, Manfredi M, Mele F, Bollito E, Fiori C. Porpiglia F, et al. Among authors: cattaneo g. J Urol. 2017 Jul;198(1):58-64. doi: 10.1016/j.juro.2017.01.036. Epub 2017 Jan 16. J Urol. 2017. PMID: 28093292
All you need to know about "Aquablation" procedure for treatment of benign prostatic obstruction.
Fiori C, Checcucci E, Gilling P, Amparore D, Volpi G, De Cillis S, Aimar R, Sica M, Cattaneo G, Alleva G, Manfredi M, Porpiglia F; ESUT Lower Tract Group. Fiori C, et al. Among authors: cattaneo g. Minerva Urol Nefrol. 2020 Apr;72(2):152-161. doi: 10.23736/S0393-2249.20.03654-1. Epub 2020 Feb 19. Minerva Urol Nefrol. 2020. PMID: 32083415 Free article. Review.
The importance of anatomical reconstruction for continence recovery after robot assisted radical prostatectomy: a systematic review and pooled analysis from referral centers.
Checcucci E, Pecoraro A, DE Cillis S, Manfredi M, Amparore D, Aimar R, Piramide F, Granato S, Volpi G, Autorino R, Fiori C, Porpiglia F; San Luigi Study Group. Checcucci E, et al. Minerva Urol Nephrol. 2021 Apr;73(2):165-177. doi: 10.23736/S2724-6051.20.04146-6. Epub 2020 Nov 17. Minerva Urol Nephrol. 2021. PMID: 33200906 Free article.
Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.
Porpiglia F, Fiori C, Bertolo R, Garrou D, Cattaneo G, Amparore D. Porpiglia F, et al. Among authors: cattaneo g. BJU Int. 2015 Aug;116(2):278-87. doi: 10.1111/bju.12982. Epub 2015 Mar 7. BJU Int. 2015. PMID: 25382816 Free article.
403 results